Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic
| dc.contributor.author | Patel, Shreya | |
| dc.contributor.author | Thompson, Misty D. | |
| dc.contributor.author | Slaven, James E. | |
| dc.contributor.author | Sanders, Don B. | |
| dc.contributor.author | Ren, Clement L. | |
| dc.contributor.department | Pediatrics, School of Medicine | en_US |
| dc.date.accessioned | 2021-04-30T17:32:29Z | |
| dc.date.available | 2021-04-30T17:32:29Z | |
| dc.date.issued | 2021-05 | |
| dc.description | This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. | en_US |
| dc.description.abstract | To assess the impact of COVID‐19 restrictions on cystic fibrosis (CF) pulmonary exacerbations (PEx) we performed a retrospective review of PEx events at our CF Center and compared the rate of PEx in 2019 versus 2020. Restrictions on social interaction due to the COVID‐19 pandemic were associated with a lower number of PEx events at our pediatric CF Center, suggesting that these restrictions also reduced exposure to other respiratory viral infection in children with CF. | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Patel, S., Thompson, M. D., Slaven, J. E., Sanders, D. B., & Ren, C. L. (2021). Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID‐19 pandemic. Pediatric pulmonology, 56(5), 1271-1273. https://doi.org/10.1002/ppul.25250 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/25832 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | en_US |
| dc.relation.isversionof | 10.1002/ppul.25250 | en_US |
| dc.relation.journal | Pediatric Pulmonology | en_US |
| dc.rights | Public Health Emergency | en_US |
| dc.source | Publisher | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | cystic fibrosis | en_US |
| dc.subject | epidemiology | en_US |
| dc.title | Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic | en_US |
| dc.type | Article | en_US |